Diet Quality Among Children

Posted by Jim Michalski

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JULY 8, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.1880?guestAccessKey=bb7f97e8-8982-49c8-81c3-62e82491fd54&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070824

 

About The Study: Although total dietary quality scores among U.S. children improved overall during 2005-2020, the increase remained suboptimal: lower than 5 points, a significant threshold for children in this analysis of changes in diet quality.

Corresponding Author: To contact the corresponding author, Yongjun Zhang, Ph.D., M.D., email zhangyongjun@sjtu.edu.cn.

 

(doi:10.1001/jamapediatrics.2024.1880)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Pandemic Stringency Measures and Hospital Admissions for Eating Disorders

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.2044?guestAccessKey=79a11038-1b2d-442c-8595-7d1e76d12e81&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070824

No Comments

Filed under:

Disparities in Psychiatric Emergency Department Boarding of Children and Adolescents

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.1991?guestAccessKey=d2792725-d524-4d5f-966d-37f3fbe81da4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070824

No Comments

Filed under:

Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity

Posted by Jim Michalski

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JULY 8, 2024

Media advisory: The full study is linked to this news release.  

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.2525?guestAccessKey=1d98a3bc-0a11-444c-a21a-2b875588f3f0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070824

 

About The Study: In this population of adults with overweight or obesity, use of tirzepatide was associated with significantly greater weight loss than semaglutide. Future study is needed to understand differences in other important outcomes. 

Corresponding Author: To contact the corresponding author, Nicholas L. Stucky, M.D., email nicholass@truveta.com.

 

(doi:10.1001/jamainternmed.2024.2525)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Acceptability of Hospital-at-Home Care and Capacity for Caregiver Burden

Posted by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 11 A.M. ET, MONDAY, JULY 8, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10035?guestAccessKey=b575190f-6bf6-4ff8-9f49-66549ee1f6f4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070824

 

About The Study: Survey respondents reported substantial acceptability of hospital-at-home care, which did not vary across sociodemographics, health insurance coverage, health status, prior hospitalizations, or telehealth use. Approximately half of respondents agreed that hospital-at-home care was effective, safe, and convenient. Most indicated capacity to perform many caregiver tasks.

Corresponding Author: To contact the corresponding author, Melissa A. Frasco, Ph.D., email mfrasco@usc.edu.

 

(doi:10.1001/jama.2024.10035)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Medicare Eligibility and Changes in Coverage, Access to Care, and Health by Sexual Orientation and Gender Identity

Posted by Jim Michalski

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, JULY 5, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.1756?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=070524

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: The findings of this cross-sectional study indicate that Medicare eligibility was not associated with consistently greater improvements in health insurance coverage and access to care among LGBTQI+ individuals compared with heterosexual and/or cisgender individuals. However, among sexual minority individuals, Medicare may be associated with closing gaps in self-reported health status, and among states with the highest disparities, it may improve health insurance coverage, access to care, and self-reported health status. 

Corresponding Author: To contact the corresponding author, Kyle A. Gavulic, B.A., email kyle.gavulic@yale.edu.

 

(doi:10.1001/jamahealthforum.2024.1756)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, FRIDAY, JULY 5, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.21305?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=070524

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: Glucagon-like peptide receptor agonists (GLP-1RAs) were associated with lower risks of specific types of obesity-associated cancers compared with insulins or metformin in patients with type 2 diabetes in this study. These findings provide preliminary evidence of the potential benefit of GLP-1RAs for cancer prevention in high-risk populations and support further preclinical and clinical studies for the prevention of certain obesity-associated cancers.

Corresponding Authors: To contact the corresponding authors, email Nathan A. Berger, M.D. (nab@case.edu) and Rong Xu, Ph.D. (rxx@case.edu).

 

(doi:10.1001/jamanetworkopen.2024.21305)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Subjective Cognitive Decline Plus and Longitudinal Assessment and Risk for Cognitive Impairment

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2024.1678?guestAccessKey=a121b795-500c-46e8-abff-4ab362a2325a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070324

No Comments

Filed under:

Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide

Posted by Jim Michalski

JAMA Ophthalmology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, JULY 3, 2024

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2024.2296?guestAccessKey=bb0f187b-7fb2-4e73-8cc1-52cd65b44324&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070324

 

About The Study: The findings of this study suggest an association between semaglutide, a glucagon-like peptide 1 receptor agonist, and nonarteritic anterior ischemic optic neuropathy. As this was an observational study, future study is required to assess causality. 

Corresponding Author: To contact the corresponding author, Joseph F. Rizzo III, M.D., email joseph_rizzo@meei.harvard.edu.

 

(doi:10.1001/jamaophthalmol.2024.2296)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Web-Based Cognitive Behavioral Treatment for Bulimia Nervosa

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, JULY 3, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.19019?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=070324

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this randomized clinical trial, a web-based cognitive behavioral self-help intervention effectively decreased eating disorder symptoms and illness-related burden in individuals with bulimia nervosa, underlining the potential of digital interventions to complement established treatments.

Corresponding Author: To contact the corresponding author, Steffen Hartmann, M.S., email steffen.hartmann@psychologie.uni-heidelberg.de.

 

(doi:10.1001/jamanetworkopen.2024.19019)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Environmental Toxicant Exposure and Depressive Symptoms

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, JULY 3, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.20259?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=070324

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The results of this study suggest that many common environmental toxicants are associated with depressive symptoms. This research provides insight into selecting environmental targets for mechanistic research into the causes of depression and facilitating efforts to reduce environmental exposures.

Corresponding Author: To contact the corresponding author, Jing Li, Ph.D., email jing.li@hsc.pku.edu.cn.

 

(doi:10.1001/jamanetworkopen.2024.20259)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

COVID-19 Vaccination and Parent-Reported Symptomatic Child Asthma Prevalence

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, JULY 3, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.19979?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=070324

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: Researchers found that higher COVID-19 vaccination rates may confer protection against symptomatic asthma in children. COVID-19 vaccination yields prophylactic benefits against SARS-CoV-2 infection for individual children and may also protect against other human coronaviruses through cross-reactive antibody responses.

Corresponding Author: To contact the corresponding author, Matthew M. Davis, M.D., M.A.P.P., email matthew.davis@nemours.org.

 

(doi:10.1001/jamanetworkopen.2024.19979)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

E-Cigarette Use and Lung Cancer Screening Uptake

Posted by Alexandra Marusarz

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JULY 2, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.19648?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=070224

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this cross-sectional study, e-cigarette use was independently associated with lower use of lung cancer screening, particularly among individuals who had quit smoking combustible cigarettes. Emerging research suggests that e-cigarettes contain definite and probable carcinogens and cause similar cancer-associated gene deregulations as combustible tobacco.

Corresponding author: To contact the corresponding author, Qian Wang, M.D., M.P.H., email qian.wang@uhhospitals.org.

 

(doi: 10.1001/jamanetworkopen.2024.17545)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

In-Hospital Delirium and Disability and Cognitive Impairment After COVID-19 Hospitalization

Posted by Alexandra Marusarz

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JULY 2, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.19640?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=070224

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this cohort study of 311 hospitalized older adults with COVID-19, in-hospital delirium was associated with increased functional disability and cognitive impairment over the 6 months following discharge. Older survivors of a COVID-19 hospitalization who experience in-hospital delirium should be assessed for disability and cognitive impairment during postdischarge follow-up.

Corresponding author: To contact the corresponding author, Lauren E. Ferrante, M.D., M.H.S., email lauren.ferrante@yale.edu.

 

(doi: 10.1001/jamanetworkopen.2024.19640)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Routine Electrocardiogram Screening and Cardiovascular Disease Events in Adults

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.2270?guestAccessKey=e22a37fd-5779-455e-84c3-0b874b5e0fb3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070124

No Comments

Filed under:

The Role of Family Support in Moderating Mental Health Outcomes for LGBTQ+ Youth in Primary Care

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.1956?guestAccessKey=e663a04f-fa67-481d-9543-032e4a615a7b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070124

No Comments

Filed under:

Fluorine-18 Prostate-Specific Membrane Antigen–1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer

Posted by Jim Michalski

JAMA Oncology

EMBARGOED FOR RELEASE: 12 P.M. (ET), MONDAY, JULY 1, 2024

Media advisory: The full study is linked to this news release. This study is being presented at the Canadian Urological Association Annual Meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.3196?guestAccessKey=2cd3fc6c-d9db-487f-9ba5-c3d143791b17&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070124

 

About The Study: In this phase 2 prospective validating paired cohort study, fluorine-18 PSMA-1007 PET/computed tomography was superior to magnetic resonance imaging (MRI) for the locoregional staging of prostate cancer. These findings support PSMA PET in the preoperative workflow of intermediate-risk and high-risk tumors. 

Corresponding Author: To contact the corresponding author, Adam Kinnaird, M.D., Ph.D., email ask@ualberta.ca.

 

(doi:10.1001/jamaoncol.2024.3196)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

COVID-19 Vaccination in the First Trimester and Major Structural Birth Defects Among Live Births

Posted by Jim Michalski

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JULY 1, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.1917?guestAccessKey=f43337ec-768e-4600-9af9-7b11928583f9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070124

 

About The Study: Among live-born infants, first-trimester mRNA COVID-19 vaccine exposure was not associated with an increased risk for selected major structural birth defects in this multisite cohort study.

Corresponding Author: To contact the corresponding author, Elyse O. Kharbanda, M.D., M.P.H., email elyse.o.kharbanda@healthpartners.com.

 

(doi:10.1001/jamapediatrics.2024.1917)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Excess US Deaths Attributable to High All-Cause Mortality Rates Among Youths

Posted by Jim Michalski

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JULY 1, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.1869?guestAccessKey=3a4ca88f-3241-47af-b25f-e0492572532e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070124

 

About The Study: The mortality gap between the U.S. and comparison countries widened in the last decade. Each year, nearly 20,000 deaths among youths ages 0 to 19 years would not have occurred had U.S. youths experienced the median mortality rates of 16 comparison countries. More than half of these deaths involved infants, reflecting disproportionately high U.S. infant mortality rates.

Corresponding Author: To contact the corresponding author, Steven H. Woolf, M.D., M.P.H., email steven.woolf@vcuhealth.org.

 

(doi:10.1001/jamapediatrics.2024.1869)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

State Cannabis and Psychedelic Legislation and Microdosing Interest in the US

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.1653?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062824

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

No Comments

Filed under:

Source-Specific Air Pollution and Loss of Independence in Older Adults Across the US

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, FRIDAY, JUNE 28, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.18460?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062824

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: This study found that long-term exposure to air pollution was associated with the need for help for lost independence in later life, with especially large and consistent increases in risk for pollution generated by traffic-related sources. These findings suggest that controlling air pollution could be associated with diversion or delay of the need for care and prolonged ability to live independently. 

Corresponding Author: To contact the corresponding author, Boya Zhang, Ph.D., email zhboya@umich.edu.

 

(doi:10.1001/jamanetworkopen.2024.18460)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Heritability of Body Mass Index Among Familial Generations

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, FRIDAY, JUNE 28, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.19029?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062824

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this study, the weight status of parents at 17 years of age was associated with obesity risk for both female and male offspring, emphasizing that parental factors may influence the next generation’s health outcomes. 

Corresponding Author: To contact the corresponding author, Gabriel Chodick, Ph.D., email chodick@tauex.tau.ac.il.

 

(doi:10.1001/jamanetworkopen.2024.19029)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Changes in Health Care and Prescription Medication Affordability During the Pandemic

Posted by Jim Michalski

JAMA Health Forum

EMBARGOED FOR RELEASE: 8 A.M. (ET), SUNDAY, JUNE 30, 2024

Media advisory: The full study is linked to this news release. This study is being presented at the AcademyHealth 2024 Annual Research Meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.1939?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=063024

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: Health care affordability improved for low-income adults during the COVID-19 pandemic, resulting in a narrowing of income-based disparities, while prescription medication affordability improved for all income groups. These findings suggest that the recent unwinding of COVID-19 pandemic–related safety-net policies may worsen health care affordability and widen existing income-based inequities. 

Corresponding Author: To contact the corresponding author, Rishi K. Wadhera, M.D., M.P.P., M.Phil., email rwadhera@bidmc.harvard.edu.

 

(doi:10.1001/jamahealthforum.2024.1939)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Changes in Emergency Contraceptive Fills After Massachusetts’ Statewide Standing Order

Posted by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 9 A.M. ET, TUESDAY, JULY 2, 2024

Media advisory: The full study is linked to this news release. This study is being presented at the AcademyHealth 2024 Annual Research Meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.11715?guestAccessKey=f61343ad-3103-4539-a281-7597e041fd9b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070224

 

About The Study: The Massachusetts statewide standing order policy was associated with a 32% increase in emergency contraceptive fills at pharmacies versus comparison states. After the policy, fills for prescription-only ulipristal more than doubled and accounted for the observed increases in fills for emergency contraceptives.

Corresponding Author: To contact the corresponding author, Dima M. Qato, Pharm.D., M.P.H., Ph.D., email qato@usc.edu.

 

(doi:10.1001/jama.2024.11715)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Household Health Care Payments Under Rate Setting, Spending Growth Target, and Single-Payer Policies

Posted by Jim Michalski

JAMA Health Forum

EMBARGOED FOR RELEASE: 8 A.M. (ET), SUNDAY, JUNE 30, 2024

Media advisory: The full study is linked to this news release. This study is being presented at the AcademyHealth 2024 Annual Research Meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.1932?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=063024

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: Single-payer financing based on the current federal income tax schedule and a payroll tax could substantially increase progressivity of household payments by income. Rate setting led to slight increases in payments by higher-income households, who financed higher payment rates in Medicare and Medicaid. Spending growth targets reduced payments slightly for all households. 

Corresponding Author: To contact the corresponding author, Jodi L. Liu, Ph.D., email jodiliu@rand.org.

 

(doi:10.1001/jamahealthforum.2024.1932)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Pay-for-Performance Incentives for Home Dialysis Use and Kidney Transplant

Posted by Jim Michalski

JAMA Health Forum

EMBARGOED FOR RELEASE: 8 A.M. (ET), SUNDAY, JUNE 30, 2024

Media advisory: The full study is linked to this news release. This study is being presented at the AcademyHealth 2024 Annual Research Meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.2055?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=063024

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: The first 2 years of the End-Stage Renal Disease Treatment Choices model were not associated with increased use of home dialysis or kidney transplant, nor changes in racial, ethnic, and socioeconomic disparities in these outcomes in this cross-sectional study. 

Corresponding Author: To contact the corresponding author, Amal N. Trivedi, M.D., M.P.H., email amal_trivedi@brown.edu.

 

(doi:10.1001/jamahealthforum.2024.2055)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Coverage and Access Changes During Medicaid Unwinding

Posted by Jim Michalski

JAMA Health Forum

EMBARGOED FOR RELEASE: 2:15 P.M. (ET), SATURDAY, JUNE 29, 2024

Media advisory: The full study is linked to this news release. This study is being presented at the AcademyHealth 2024 Annual Research Meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.2193?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062924

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: The results of this survey study indicated that 6 months into unwinding, 1 in 8 Medicaid beneficiaries reported exiting the program, with wide state variation. Roughly half who lost Medicaid coverage became uninsured. Among those moving to new coverage, many experienced coverage gaps. Adults exiting Medicaid reported more challenges accessing care than respondents who remained enrolled. 

Corresponding Author: To contact the corresponding author, Adrianna McIntyre, Ph.D., M.P.H., M.P.P., email amcintyre@hsph.harvard.edu.

 

(doi:10.1001/jamahealthforum.2024.2193)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Geographic Disparities in Head and Neck Cancer Mortality and Place of Death

Posted by Jim Michalski

JAMA Otolaryngology–Head & Neck Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 27, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2024.1650?guestAccessKey=964d0fff-3073-49f4-a0bc-cc885a7bc8a4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062724

 

About The Study: Rural residents with head and neck cancer experienced higher mortality rates and less annual improvement compared to urban counterparts in this cross-sectional study. Multilevel barriers may explain the widening rural-urban mortality gap, including alcohol and tobacco use and lower human papillomavirus (HPV) vaccination rates.

Corresponding Author: To contact the corresponding author, S. M. Qasim Hussaini, M.D.,M.S., email shussaini@uabmc.edu.

 

(doi:10.1001/jamaoto.2024.1650)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Suicide Mortality During the Perinatal Period

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, THURSDAY, JUNE 27, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.18887?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062724

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: This study provides insights into complex factors surrounding maternal suicide, and it highlights opportunities for further research to understand long-term consequences of perinatal mental health. These findings also underscore the need for targeted evidence-based interventions and effective policies targeting mental health, substance use, and intimate partner problems to prevent maternal suicide and enhance maternal health outcomes. 

Corresponding Author: To contact the corresponding author, Kara Zivin, Ph.D., M.S., M.A., M.F.A., email kzivin@umich.edu.

 

(doi:10.1001/jamanetworkopen.2024.18887)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Antibiotic Treatment and Health Care Use in Children and Adolescents With Conjunctivitis

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2024.2211?guestAccessKey=9cdedb59-5613-4a57-aee4-525a9b24449a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062724

No Comments

Filed under:

Endometrial Thickness as Diagnostic Triage for Endometrial Cancer Among Black Individuals

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.1891?guestAccessKey=bc895934-8d94-4941-9960-8ba010ab5a7d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062724

No Comments

Filed under:

Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, JUNE 26, 2024

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.18729?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062624

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: Multivitamin use was not associated with a mortality benefit in this cohort study of U.S. adults. Still, many adults report using multivitamins to maintain or improve health. 

Corresponding Author: To contact the corresponding author, Erikka Loftfield, Ph.D., M.P.H., email erikka.loftfield@nih.gov.

 

(doi:10.1001/jamanetworkopen.2024.18729)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Psychosis in Alzheimer Disease and Elevations in Disease-Relevant Biomarkers

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2024.1389?guestAccessKey=669aa438-3dfb-4f3f-9ef4-63d7a12e65f6&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062624

No Comments

Filed under:

Acupuncture and Sleep Quality Among Patients With Parkinson Disease

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.17862?guestAccessKey=546456e2-def1-40e3-99f9-d781c52cbc0e&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062624

No Comments

Filed under:

Engagement With a Mobile Chat-Based Intervention for Smoking Cessation

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.17796?guestAccessKey=546456e2-def1-40e3-99f9-d781c52cbc0e&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062624

No Comments

Filed under:

Premature Death, Suicide, and Nonlethal Intentional Self-Harm After Psychiatric Discharge

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.17131?guestAccessKey=546456e2-def1-40e3-99f9-d781c52cbc0e&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062624

No Comments

Filed under:

Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.18808?guestAccessKey=11add3e8-5430-44bc-8cb6-cb8192fd8f83&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062624

No Comments

Filed under:

Epidemiology of Opioid Prescribing After Discharge From Surgical Procedures Among Adults

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.17651?guestAccessKey=bf2e2876-3d39-4abb-87c8-5938e785389f&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062624

No Comments

Filed under:

Use of Oral and Emergency Contraceptives After the Supreme Court’s Dobbs Decision

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, WEDNESDAY, JUNE 26, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.18620?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062624

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this cohort study of prescriptions filled at U.S. pharmacies, the Dobbs decision was associated with declines in oral contraceptives, particularly emergency contraceptives, in states enacting the most restrictive abortion policies. Given the important role of oral contraceptive pills and emergency contraceptives in preventing pregnancy and the need for abortion, efforts to improve access may be needed, especially in states where legal abortion is no longer an option.

Corresponding Author: To contact the corresponding author, Dima M. Qato, Pharm.D., M.P.H., Ph.D., email qato@usc.edu.

 

(doi:10.1001/jamanetworkopen.2024.18620)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, TUESDAY, JUNE 25, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.16775?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062524

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The combination of exercise and glucagon-like peptide-1 receptor agonist (GLP-1RA) (liraglutide) was the most effective weight loss strategy while preserving bone health in this randomized clinical trial. Liraglutide treatment alone reduced bone mineral density at clinically relevant sites more than exercise alone despite similar weight loss.

Corresponding Author: To contact the corresponding author, Signe Sorensen Torekov, Ph.D., email torekov@sund.ku.dk.

 

(doi:10.1001/jamanetworkopen.2024.16775)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Physical, Sexual, and Intimate Partner Violence Among Transgender and Gender-Diverse Individuals

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, TUESDAY, JUNE 25, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.19137?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062524

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this survey study of adults in California, results showed that transgender and gender-diverse individuals, especially transgender men, are at higher risk of experiencing all forms of violence relative to cisgender women. Results highlight the need for gender-affirming violence prevention and intervention services as well as policies that protect transgender and gender-diverse individuals from discriminatory violence.

Corresponding Author: To contact the corresponding author, Sabrina C. Boyce, Ph.D., email boyce.sabrina@berkeley.edu.

 

(doi:10.1001/jamanetworkopen.2024.19137)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Comparison of No-Test Telehealth and In-Person Medication Abortion

Posted by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 11 A.M. ET, MONDAY, JUNE 24, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.10680?guestAccessKey=9a062794-a7aa-4674-9b7e-e3fb459b4f45&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062424

 

About The Study: This prospective, observational study found that medication abortion obtained following no-test telehealth screening and mailing of medications was associated with similar rates of complete abortion compared with in-person care with ultrasonography and met prespecified criteria for noninferiority, with a low prevalence of adverse events.

 

Quote from corresponding author Lauren J. Ralph, Ph.D., M.P.H.:

“This is a prospective, observational study comparing patients who received medication abortion care remotely and without ultrasound to those who went in person to a facility and got an ultrasound. Using data from patient surveys and their medical record, we found no differences in effectiveness of medication abortion by how they received the medications, and low prevalence of adverse events across all groups.
“No-test, telehealth medication abortion is as effective as in person care with ultrasound, and safe overall. This model of care should be offered as an option to all pregnant people seeking abortion.
“I hope that these findings are reassuring to both clinicians and patients that medication abortion using no-test, telehealth and mailing of medications is as effective as in person care with ultrasound. These models offer a safe, effective and urgently needed way to overcome logistical and geographic obstacles to accessing abortion today.
“Despite continued efforts to restrict access to medication abortion, for example by requiring in person dispensing of the medications, the research has consistently been clear that medication abortion with no-test eligibility assessment and mailing of medications is just as effective as in person care with ultrasound.”

 

Contact information for Lauren J. Ralph, Ph.D., M.P.H.: email Lauren.Ralph@ucsf.edu. 

 

(doi:10.1001/jama.2024.10680)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Infant Deaths After Texas’ 2021 Ban on Abortion in Early Pregnancy

Posted by Jim Michalski

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JUNE 24, 2024

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.0885?guestAccessKey=7d568a16-aea5-41e6-bb65-f9c586b2ecb0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062424

 

About The Study: This study found that Texas’ 2021 ban on abortion in early pregnancy was associated with unexpected increases in infant and neonatal deaths in Texas between 2021 and 2022. Congenital anomalies, which are the leading cause of infant death, also increased in Texas but not the rest of the U.S. Although replication and further analyses are needed to understand the mechanisms behind these findings, the results suggest that restrictive abortion policies may have important unintended consequences in terms of trauma to families and medical cost as a result of increases in infant mortality. These findings are particularly relevant given the recent Dobbs v Jackson Women’s Health Organization U.S. Supreme Court decision and subsequent rollbacks of reproductive rights in many U.S. states.

Corresponding Author: To contact the corresponding author, Alison Gemmill, Ph.D., email agemmill@jhu.edu.

 

(doi:10.1001/jamapediatrics.2024.0885)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Identifying and Measuring Administrative Harms Experienced by Hospitalists and Administrative Leaders

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.1890?guestAccessKey=c7fddfb6-daee-4bca-a826-e100386c93c7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062424

No Comments

Filed under:

Cardiovascular Risk Factors in Childhood and Adulthood and Cardiovascular Disease in Middle Age

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, MONDAY, JUNE 24, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.18148?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062424

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: In this cohort study of 10,634 participants, childhood risk factors were found to be associated both directly and indirectly to adult cardiovascular disease (CVD), with the largest direct effect seen for body mass index (BMI) and low-density lipoprotein cholesterol. These findings suggest that intervention for childhood risk factors, in particular BMI, is warranted to reduce incidence of adult CVD as it cannot be fully mitigated by risk factor management in adulthood.

Corresponding Author: To contact the corresponding author, Terence Dwyer, M.D., email terence.dwyer@wrh.ox.ac.uk.

 

(doi:10.1001/jamanetworkopen.2024.18148)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Health Status and Mental Health of Transgender and Gender-Diverse Adults

Posted by Jim Michalski

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JUNE 24, 2024

Media advisory: The full study and commentary are linked to this news release.  

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.2544?guestAccessKey=b1600772-dd9a-40a5-bcbc-a31fbb4b8a10&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062424

 

About The Study: Health status, mental health, and health inequities among transgender and gender-diverse adults in the U.S. worsened from 2014 to 2022. This population experienced over 2-fold increases in prevalence of frequent mental distress and depression, while significantly smaller changes were observed among their cisgender counterparts. 

Corresponding Author: To contact the corresponding author, Michael Liu, M.Phil., email mliu02@hms.harvard.edu.

 

(doi:10.1001/jamainternmed.2024.2544)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Estimated Effectiveness of Pfizer-BioNTech Vaccine Against COVID-19

Posted by Jim Michalski

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JUNE 24, 2024

Media advisory: The full study and commentary are linked to this news release.  

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2024.1640?guestAccessKey=c629e5aa-720c-489c-88fc-4c744e4ab6c0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062424

 

About The Study: The findings of this case-control study reaffirm current recommendations for broad age-based use of annually updated COVID-19 vaccines given that (1) the BNT162b2 XBB vaccine (Pfizer-BioNTech; 2023-2024 formulation) provided statistically significant additional protection against a range of COVID-19 outcomes and (2) older versions of COVID-19 vaccines offered little, if any, long-term protection, including against hospital admission, regardless of the number or type of prior doses received.  

Corresponding Author: To contact the corresponding author, Sara Y. Tartof, Ph.D., M.P.H., email sara.y.tartof@kp.org.

 

(doi:10.1001/jamainternmed.2024.1640)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Determining Associations Between Intervention Amount and Outcomes for Young Autistic Children

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.1832?guestAccessKey=083c9307-fb06-4d1c-83f8-dbbe7dedef5c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062424

No Comments

Filed under:

Social Media Use and Internalizing Symptoms in Clinical and Community Adolescent Samples

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2024.2078?guestAccessKey=2848bef5-74ae-4d57-a4f7-53bec0e1b3a8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062424

No Comments

Filed under:

Racial and Ethnic and Rural Variations in Access to Primary Care for Veterans Following the MISSION Act

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.1568?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062124

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

No Comments

Filed under:

Increasing Voter Participation Through Health Care–Based Voter Registration

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2024.1563?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062124

About JAMA Health Forum: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

No Comments

Filed under:

A 5:2 Intermittent Fasting Meal Replacement Diet and Glycemic Control for Adults With Diabetes

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, FRIDAY, JUNE 21, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.16786?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062124

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: This randomized clinical trial of Chinese adults with overweight or obesity and with early type 2 diabetes found that an intermittent fasting plan consisting of two nonconsecutive fasting days and five days of habitual intake per week and meal replacement diet (5:2 MR) could improve glycemic outcomes and weight loss in the short term compared with metformin or empagliflozin, making it a promising initial intervention and early management for type 2 diabetes.

Corresponding Author: To contact the corresponding author, Lixin Guo, M.D., email glx1218@163.com.

 

(doi:10.1001/jamanetworkopen.2024.16786)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Cannabis, Tobacco Use, and COVID-19 Outcomes

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, FRIDAY, JUNE 21, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.17977?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062124

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The findings of this cohort study suggest that cannabis use may be an independent risk factor for COVID-19–related complications, even after considering cigarette smoking, vaccination status, comorbidities, and other risk factors. 

Corresponding Author: To contact the corresponding author, Li-Shiun Chen, M.D., M.P.H., Sc.D., email li-shiun@wustl.edu.

 

(doi:10.1001/jamanetworkopen.2024.17977)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under:

Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults

Posted by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.9673?guestAccessKey=62c3c79b-4649-40c7-9f07-ee7a047b8330&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062024

No Comments

Filed under:

Prenatal Maternal Psychological Distress During the Pandemic and Newborn Brain Development

Posted by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. ET, THURSDAY, JUNE 20, 2024

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.17924?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=062024

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

 

About The Study: The findings of this study suggest that increased maternal mental health symptoms during the COVID-19 pandemic are associated with subsequent changes in regional brain growth in newborn offspring. 

Corresponding Author: To contact the corresponding author, Nickie Andescavage, M.D., email nniforat@childrensnational.org.

 

(doi:10.1001/jamanetworkopen.2024.17924)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

No Comments

Filed under: